Vitamin D receptor FokI gene polymorphisms may be associated with colorectal cancer among African American and Hispanic participants

Cancer

Volumn 120, Issue 9, 2014, Pages 1387-1393

  Sarkissyan, Marianna ^a   Wu, Yanyuan ^a,b   Chen, Zujian ^a   Mishra, Dhruva K ^a   Sarkissyan, Suren ^a   Giannikopoulos, Ioannis ^a   Vadgama, Jaydutt V ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African American; colorectal cancer; genetic polymorphism; Hispanic; vitamin D receptor

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD SAMPLING; CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; ETHNICITY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D RECEPTOR APAI GENE; VITAMIN D RECEPTOR BSMI GENE; VITAMIN D RECEPTOR FOKI GENE; VITAMIN D RECEPTOR TAQI GENE;

AFRICAN AMERICAN; COLORECTAL CANCER; GENETIC POLYMORPHISM; HISPANIC; VITAMIN D RECEPTOR;

AFRICAN AMERICANS; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES;

EID: 84899473696     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28565     Document Type: Article

References (33)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. McCullough ML, Bostick RM, Mayo TL,. Vitamin D gene pathway polymorphisms and risk of colorectal, breast, and prostate cancer. Annu Rev Nutr. 2009; 29: 111-132.
3. Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003; 95: 1765-1771.
4. Fedirko V, Bostick RM, Flanders WD, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009; 2: 213-223.
5. Zhang X, Giovannucci E,. Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract Res Clin Gastroenterol. 2011; 25: 485-494.
6. Freedman DM, Looker AC, Chang SC, Graubard BI,. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst. 2007; 99: 1594-1602.
7. Giovannucci E, Liu Y, Willett WC,. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2467-2472.
8. Gutierrez OM, Farwell WR, Kermah D, Taylor EN,. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011; 22: 1745-1753.
9. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007; 167: 1159-1165.
10. Fiscella K, Winters P, Tancredi D, Hendren S, Franks P,. Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute? Cancer. 2011; 117: 1061-1069.
11. Ahearn TU, McCullough ML, Flanders WD, et al. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res. 2011; 71: 413-423.
12. Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM,. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on the APC/beta-catenin pathway in the normal mucosa of colorectal adenoma patients. Cancer Prev Res (Phila). 2012; 5: 1247-1256.
13. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006; 354: 684-696.
14. Buttigliero C, Monagheddu C, Petroni P, et al. Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. Oncologist. 2011; 16: 1215-1227.
15. Lamprecht SA, Lipkin M,. Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer. 2003; 3: 601-614.
16. Alimirah F, Peng X, Murillo G, Mehta RG,. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells [serial online]. PLoS One. 2011; 6: e16024.
17. Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000; 14: 401-420.
18. Murtaugh MA, Sweeney C, Ma KN, et al. Vitamin D receptor gene polymorphisms, dietary promotion of insulin resistance, and colon and rectal cancer. Nutr Cancer. 2006; 55: 35-43.
19. Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ,. Assessing noncancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol. 2013; 178: 339-349.
20. Ochs-Balcom HM, Cicek MS, Thompson CL, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008; 29: 1788-1793.
21. Park K, Woo M, Nam J, Kim JC,. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Lett. 2006; 237: 199-206.
22. Raimondi S, Johansson H, Maisonneuve P, Gandini S,. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009; 30: 1170-1180.
23. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR,. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999; 83: 723-726.
24. Trabert B, Malone KE, Daling JR, et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women [serial online]. Breast Cancer Res. 2007; 9: R84.
25. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
26. Mishra DK, Wu Y, Sarkissyan M, et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African-American and Hispanic women [serial online]. PLoS One. 2013; 8: e57967.
27. Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC,. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012; 18: 1672-1679.
28. Poynter JN, Jacobs ET, Figueiredo JC, et al. Genetic variation in the vitamin D receptor (VDR) and the vitamin D-binding protein (GC) and risk for colorectal cancer: results from the Colon Cancer Family Registry. Cancer Epidemiol Biomarkers Prev. 2010; 19: 525-536.
29. Fedirko V, Riboli E, Tjonneland A, et al. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European populations. Cancer Epidemiol Biomarkers Prev. 2012; 21: 582-593.
30. Peters U, McGlynn KA, Chatterjee N, et al. Vitamin D, calcium, and vitamin D receptor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2001; 10: 1267-1274.
31. Slatter ML, Yakumo K, Hoffman M, Neuhausen S,. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 2001; 12: 359-364.
32. Slattery ML, Murtaugh M, Caan B, Ma KN, Wolff R, Samowitz W,. Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control. 2004; 15: 863-872.
33. Lee JE,. Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: a meta-analysis. Nutr Res Pract. 2011; 5: 464-470.